Dr. Maher Abdul Hay, MD
Claim this profileStudies Graft-versus-Host Disease
Studies GVHD
1 reported clinical trial
3 drugs studied
More about Maher Abdul Hay, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Maher Abdul Hay, MD has experience with
- Abatacept
- Bortezomib
- Cyclophosphamide
Breakdown of trials Maher Abdul Hay, MD has run
Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maher Abdul Hay, MD specialize in?
Maher Abdul Hay, MD focuses on Graft-versus-Host Disease and GVHD. In particular, much of their work with Graft-versus-Host Disease has involved β-hCG negative patients, or patients who are undergoing treatment.
Is Maher Abdul Hay, MD currently recruiting for clinical trials?
No, Maher Abdul Hay, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Maher Abdul Hay, MD has studied deeply?
Yes, Maher Abdul Hay, MD has studied treatments such as Abatacept, Bortezomib, Cyclophosphamide.
What is the best way to schedule an appointment with Maher Abdul Hay, MD?
Apply for one of the trials that Maher Abdul Hay, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.